Dr. Raphael Darvish, MD

Dr. Darvish practices at Brentview Medical Urgent Care - Los Angeles in Los Angeles, California.

Dr. Darvish's NPI, 1245457811, was assigned on April 18, 2007. Dr. Darvish graduated from University of California, Geffen School of Medicine in 2004. Dr. Darvish holds California license A92794.

Dr. Darvish's primary practice is Brentview Medical Urgent Care - Los Angeles, at 11611 W San Vicente Blvd, Los Angeles, CA 90049. The practice phone is (310) 820-0013.

Dr. Darvish's primary practice is Brentview Medical Urgent Care - Los Angeles in Los Angeles, California. The medical group on file is Brentview Medical Urgent Care. Dmand AI also links Dr. Darvish to 1 more group practice or clinic, 1 therapy and rehab clinic and 1 medical group, each named with a free account. Dr. Darvish's employer is on file too: an urgent care center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Darvish practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Darvish's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Darvish is licensed in California.

CMS data shows 90 Medicare services from Dr. Darvish across 3 procedure codes in 2024, all of them office visits, for 71 Medicare patients. Medicare paid $7,022 for them. Every service was in an office.

CMS counts 71 Medicare patients who saw Dr. Darvish in 2024. The largest group is 65 to 74, with 32 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 27% are also on Medicaid. Their average risk score is 0.89, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Darvish's median patient age at 39, with 53% women.

In 2024, Dr. Darvish wrote 102 Medicare Part D claims for 42 patients. 88% of them were for generic drugs. CMS names the drug for 42 of them, across 3 drugs with 11 or more claims each, at $720 in total drug cost. In 2022, CMS named 26 claims across 2 drugs.

Dr. Darvish accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 36 procedures of removal of skin lesions by Dr. Darvish, more than 70% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 152 general payments to Dr. Darvish from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Allergan Inc. paid the most, $1,185.

Dr. Darvish graduated from University of California, Geffen School of Medicine in 2004.